Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria.
Kiga K, Tan XE, Ibarra-Chávez R, Watanabe S, Aiba Y, Sato'o Y, Li FY, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, Cui L.
Kiga K, et al. Among authors: ibarra chavez r.
Nat Commun. 2020 Jun 10;11(1):2934. doi: 10.1038/s41467-020-16731-6.
Nat Commun. 2020.
PMID: 32523110
Free PMC article.